ibritumomab tiuxetan

Preferred Label : ibritumomab tiuxetan;

MeSH note : 90Y-labeled anti-CD20 monoclonal antibody for radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma;

CISMeF synonym : IDEC brand of ibritumomab tiuxetan; IDEC-Y2B8; yttrium-90-ibritumomab tiuxetan; zevalin;

MeSH hyponym : IDEC-Y2B8 IDEC-129; IDEC-129;

Is substance : O;

UNII : 4Q52C550XK;

Details

Origin ID

C422802;

UMLS CUI

C0877880;

Currated CISMeF NLP mapping
- Ibritumomab Tiuxetan [NCIt concept]
- Ibritumomab tiuxetan [SMS substance]
- Ibritumomab tiuxetan (substance) [SNOMED CT concept]
MeSH indexing information
- antigens, CD20 [MeSH Descriptor]
- lymphoma, B-cell [MeSH Descriptor]
- yttrium radioisotopes [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Record concept(s)
- IDEC-Y2B8 [MeSH concept]
- ibritumomab tiuxetan [MeSH concept]
- yttrium-90-ibritumomab tiuxetan [MeSH concept]
- zevalin [MeSH concept]
See also inter- (CISMeF)
- Product containing ibritumomab tiuxetan (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Yttrium Y-90 Ibritumomab Tiuxetan [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients